Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Dermatology Physician in Ocala, FL
NPI: 1043218860Primary Employer
Suncoast Skin Solutions
suncoastskin.com
HQ Phone
Get M.D. Frederick's Phone Numberphone_androidMobile
Get M.D. Frederick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1980 - 2027
American Board of Dermatology
Dermatology
Duke University School Of Medicine
medschool.duke.edu
Medical School
Until 1971
Duke University Hospital
Residency • Dermatology
1975 - 1978
University of Florida
Residency • Internal Medicine
1971 - 1973
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 335 | 401 |
| 2 | 17000Destruction of skin growth | 325 | 403 |
| 3 | 17003Destruction of 2-14 skin growths | 248 | 1,278 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 212 | 254 |
| 5 | 17110Destruction of up to 14 skin growths | 207 | 235 |
Therapies for Psoriasis: Clinical and Economic Comparisons.
Authors: Tina Bhutani-Jacques, Benjamin Lockshin
Journal: J Drugs Dermatol
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: 80 mg Ixekizumab Dosing Regimens 1, 2, and 3
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: 80 mg ixekizumab, DRUG: 50 mg etanercept